WMSA
PACB icon

Weiss Multi-Strategy Advisers’s Pacific Biosciences PACB Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,000
Closed -$141K – 476
2016
Q2 		$141K Buy
+20,000
New +$183K 0.01% 386
2014
Q1 		– Sell
-10,000
Closed -$52K – 1085
2013
Q4 		$52K Sell
10,000
-20,000
-67% -$91.8K ﹤0.01% 956
2013
Q3 		$166K Buy
+30,000
New +$104K ﹤0.01% 875

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Weiss Multi-Strategy Advisers's PACB Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Pacific Biosciences (PACB) in Q1 2024, closing a stake of 89,396 shares — an estimated $877K sold.

Weiss Multi-Strategy Advisers first reported a position in PACB in Q2 2013 and held it in 41 quarters. The position peaked at $13M in Q1 2020. 268 funds tracked by Wall St. Rank hold PACB as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Pacific Biosciences position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 89,396 Pacific Biosciences shares in Q1 2024, an estimated $877K.
  • Weiss Multi-Strategy Advisers first reported a position in Pacific Biosciences in Q2 2013 and held it in 41 quarters.
  • Weiss Multi-Strategy Advisers's Pacific Biosciences position peaked at $13M in Q1 2020.
  • 268 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.